Evolva receives funding from the Global Cardiovascular Innovation Center
06-Nov-2008 -
Evolva announced that it has received a $288,000 award from the Cleveland Clinic led Global Cardiovascular Innovation Center (GCIC). The funding is to advance the development of Evolva’s EV-077 compound series for cardiovascular disease and to explore the formation of a dedicated cardiovascular ...
cardiovascular diseases
Evolva
Formation
+1